High cell density induces vascular endothelial growth factor expression via protein tyrosine phosphorylation

Gene Expression

Volumn 7, Issue 1, 1998, Pages 53-60

  Mukhopadhyay, Debabrata ^a   Tsiokas, Leonidas ^b   Sukhatme, Vikas P ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cancer; Cell density; Gene regulation; Protein tyrosine phosphorylation; VEGF; Von Hippel Lindau (VHL)

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE; TIOGUANINE; VASCULOTROPIN;

ARTICLE; CANCER; CANCER CELL CULTURE; CELL DENSITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTO ONCOGENE; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL COUNT; ENDOTHELIAL GROWTH FACTORS; HUMANS; LYMPHOKINES; OXYGEN; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RNA, MESSENGER; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0031901109     PISSN: 10522166     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Adamis, A. P.; Miller, J. W.; Bernal, M. T.; D'Amico, D. J.; Folkman, J.; Yeo, T. K.; Yeo, K. T. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am. J. Ophthalmol. 118:445-450; 1994.
2. Berse, B.; Brown, L. F.; Van De Water, L.; Dvorak, H. F.; Senger, D. R. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol. Biol. Cell 3:211-220; 1992.
3. Chen, F.; Kishida, T.; Duh, F-M.; Renbaum, P.; Orcutt, M. L.; Schmidt, L.; Zbar, B. Suppression of growth of renal carcinoma cells by the von Hippel-Lindau tumor suppressor gene. Cancer Res. 55: 4804-4807; 1995.
4. Chomczynski, P.; Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocynatephenol-chloroform extraction. Anal. Biochem. 162: 156-159; 1987.
5. Crossey, P. A.; Richards, F. M.; Foster, K.; Green, J. S.; Prowse, A.; Latif, F.; Lerman, M. I.; Zbar, B.; Affara, N. A.; Ferguson-Smith, M. A.; Maher, E. R. Identification of intragenic mutations in the von Hippel-Lindau disease tumor suppressor gene and correlation with disease phenotype. Hum. Mol. Genet. 3:1303-1308; 1994.
6. Ellis, L. M.; Liu, W. Vascular endothelial growth factor (VEGF) expression and alternate splice in non-metastatic and metastatic human colon cancer cell lines. Proc. Ann. Meet. Am. Cancer Res. 36: A524; 1995.
7. Fidler, I. J.; Ellis, L. M. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79:185-188; 1994.
8. Folkman, J. Fighting cancer by attacking its blood supply. Sci. Am. 275:150-4; 1996.
9. Folkman, J. The role of angiogenesis in tumor growth. Semin. Cancer Biol. 3:65-71; 1992.
10. Folkman, J.; Shing, Y. Angiogenesis. J. Biol. Chem. 267:10931-10934; 1992.
11. Gnarra, J. R.; Tory, K.; Weng, Y.; Schmidt, L.; Wei, M. H.; Li, H.; Latif, F.; Liu, S.; Chen, F.; Duh, F-M.; Lubensky, I.; Duan, D. R.; Florence, C.; Pozzatti, R.; Walther, M. M.; Bander, N. H.; Grossman, H. B.; Brauch, H.; Pomer, S.; Brooks, J. D.; Isaacs, W. B.; Lerman, M. L; Zbar, B.; Linehan, W. M. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nature Genet. 7:85-90; 1994.
12. Kibel, A.; Iliopoulos, O.; DeCaprio, J. A.; Kaelin, W. G. J. Binding of the von Hippel-Lindau tumor suppressor protein to elongin B and C. Science 269: 1444-1446; 1995.
13. Kim, K. J.; Li, B.; Winer, J.; Armanini, M.; Gillett, N.; Phillips, H. S.; Ferrara, N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362:841-844; 1993.
14. Koura, A. N.; Liu, W.; Kitadai, Y.; Singh, R. K.; Radinsky, R.; Ellis, L. M. Regulation of vascular endothelial growth factor expression in human colon carcinoma cells by cell density. Cancer Res. 56: 3891-3894; 1996.
15. Latif, F.; Tory, K.; Gnarra, J.; Yao, M.; Duh, F-M.; Orcutt, M. L.; Stackhouse, T.; Kuzmin, I.; Modi, W.; Geil, L.; Schmidt, L.; Zhou, F.; Li, H.; Wei, M. H.; Chen, F.; Glenn, G.; Choyke, P.; Walther, M. M.; Weng, Y.; Duan, D-S. R.; Dean, M.; Glavac, D.; Richards, F. M.; Crossey, P. A.; Ferguson-Smith, M. A.; Paslier, D. L.; Chumakov, L.; Cohen, D.; Chinault, A. C.; Maher, E. R.; Linehan, W. M.; Zbar, B.; Lerman, M. I. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260:1317-1320; 1993.
16. Lee, S.; Chen, D. Y. T.; Humphrey, J. S.; Gnarra, J. R.; Linehan, W, M.; Klausner, R. D. Nuclear/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell density. Proc. Natl. Acad. Sci. USA 93:1770-1775; 1996.
17. Leung, D. W.; Cachianes, G.; Kuang, W-J.; Goeddel, D. V.; Ferrara, N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309; 1989.
18. Liotta, L. A.; Steeg, P. S.; Stetler-Stevenson, W. G. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64: 327-336; 1991.
19. Maher, E. R.; Yates, J. R.; Harries, R.; Benjamin, C.; Harris, R.; Moore, A. T.; Ferguson-Smith, M. A. Clinical features and natural history of von Hippel-Lindau disease. Q. J. Med. 77:1151-1163; 1990.
20. Millauer, B.; Shawver, L.; Plate, K.; Risau, W.; Ullrich, A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367: 576-579; 1994.
21. Miller, J. W.; Adamis, A. P.; Shima, D. T.; D'A-more, P. A.; Moulton, R. S.; O'Reilly, M. S.; Folkman, J.; Dvorak, H. F.; Brown, L. F.; Berse, B.; Yeo, T-K.; Yeo, K-T. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am. J. Pathol. 145:574-584; 1994.
22. Mukhopadhyay, D.; Tsiokas, L.; Zhou, X. M.; Foster, D.; Brugge, J. S.; Sukhatme, V. P. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature 375:577-81; 1995.
23. Plate, K. H.; Breier, G.; Weich, H. T.; Risau, W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359:845-848; 1992.
24. Shweiki, D.; Itin, A.; Soffer, D.; Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845; 1992.
25. Weidner, N.; Carroll, P. R.; Flax, J.; Blumenfeld, W.; Folkman, J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am. J. Pathol. 143:401-409; 1993.
26. Weidner, N.; Semple, J. P.; Welch, W. R.; Folkman, J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N. Engl. J. Med. 324:1-8; 1991.
27. Wizigmann-Voos, S.; Breier, G.; Risau, W.; Plate, K. H. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas. Cancer Res. 55:1358-1364; 1995.
28. Zhang, H. T.; Craft, P.; Scott, P. A.; Ziehe, M.; Weich, H. A.; Harris, A. L. Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells. J. Natl. Cancer Inst. 87:213-219; 1995.